John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 6,248 shares at $261.57 ($1.6M) on 2025-06-23, disclosed to the SEC on 2025-06-25.
Open-market sale of $1.6M ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.57 | 3,074 | $804K | 49.2% |
| 2 | $261.57 | 3,074 | $804K | 49.2% |
| 3 | $262.90 | 100 | $26K | 1.6% |
| Total | $261.59 avg | 6,248 | $1.6M | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-14 | $18.3M | — | Filing → |